MCP-1 Levels in Ovarian Cancer Patients
Author Information
Author(s): Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S, Reinthaller A, Kainz C
Primary Institution: University of Vienna Medical School
Hypothesis
The study aims to evaluate the role of MCP-1 in ovarian cancer and its potential as a differentiation and prognostic marker.
Conclusion
MCP-1 may help differentiate between benign ovarian cysts and ovarian cancer but does not predict disease-free or overall survival.
Supporting Evidence
- MCP-1 levels were significantly higher in primary ovarian cancer patients compared to benign cysts and healthy women.
- MCP-1 showed a significant correlation with histological grade and age at diagnosis.
- Elevated MCP-1 levels did not correlate with disease-free or overall survival.
Takeaway
MCP-1 is a substance in the blood that can help doctors tell if someone has ovarian cancer instead of just a harmless cyst.
Methodology
This retrospective study analyzed serum levels of MCP-1 in ovarian cancer patients compared to those with benign cysts and healthy women.
Limitations
The study is retrospective and does not establish causation.
Participant Demographics
The study included 86 ovarian cancer patients, 67 patients with benign ovarian cysts, and 42 healthy women.
Statistical Information
P-Value
P < 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website